Dataset summary
TF Name: | MYOD1 | Species: | Mus musculus |
Cell-type/Tissue: | brown preadipocytes | Condition/Source: | |
JASPAR ID: | MA0499.2 | Collections: | Permissive Robust |
References: | GEO GSE50465 GSM1219688 GTRD EXP032355 |
Statistical details
Model | Peak caller | Model ID | Enrichment Zone | TFBSs | Score threshold | Centrality p-value (log10) |
---|---|---|---|---|---|---|
DAMO | MACS | MA0499.2 | 73 | 21645 | 87 | -74.2549701636646 |
37 datasets found for the same TF (MYOD1) in other cell-types/tissues
TF Name | Cell-line | Condition/Source | Collections | Species | Identifiers | JASPAR ID |
---|---|---|---|---|---|---|
MYOD1 | myocytes | 10 hours in differentiating medium | Permissive Robust | Mus musculus | GSE24852 ... | MA0499.2 |
MYOD1 | myotube | 48 hours in differentiating medium | Permissive Robust | Mus musculus | GSE24852 ... | MA0499.2 |
MYOD1 | P19 (embryonic carcinoma) | MyoD transduction | Permissive Robust | Mus musculus | GSE64626 ... | MA0499.2 |
MYOD1 | P19 (embryonic carcinoma) | MyoD transduction | Permissive Robust | Mus musculus | GSE64626 ... | MA0499.2 |
MYOD1 | C2C12 (myoblasts) | day3 of differentiation | Permissive Robust | Mus musculus | GSE80812 ... | MA0499.2 |
MYOD1 | C2C12 (myoblasts) | day3 of differentiation, KLF5 KO | Permissive Robust | Mus musculus | GSE80812 ... | MA0499.2 |
MYOD1 | C2C12 (myoblasts) | differentiated | Permissive Robust | Mus musculus | GSE63716 ... | MA0499.2 |
MYOD1 | C2C12 (myoblasts) | Day: 2 of differentiation Celltype: myoblast | Permissive | Mus musculus | GSE69527 ... | MA0499.2 |
MYOD1 | C2C12 (myoblasts) | Day: 2 of differentiation Celltype: myoblast Genotype: siRNA-mediated knockdown of Myolinc Treatment: transient siRNA transfection (10nM final concentration) was carried out using RNAiMax (Life Technologies) according to the manufacturer’s protocol | Permissive | Mus musculus | GSE69527 ... | MA0499.2 |
MYOD1 | embryonic stem cells | Treatment: doxycycline Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac | Permissive | Mus musculus | GSE97712 ... | MA0499.2 |
MYOD1 | embryonic stem cells | Treatment: no doxycycline no Source: SA-tTA-MyoD Embryonic Stem Cells Strain: MC1 mouse ES cells derived from 129S6/SvEvTac | Permissive Robust | Mus musculus | GSE97712 ... | MA0499.2 |
MYOD1 | Gastrocnemius muscle | Sex: male Strain: C57bl6 Time: collection on 24 hour timecourse | Permissive Robust | Mus musculus | GSE122082 ... | MA0499.2 |
MYOD1 | primary myoblasts | Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP; | Permissive Robust | Mus musculus | GSE127998 ... | MA0499.2 |
MYOD1 | primary myoblasts | Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with GFP; | Permissive Robust | Mus musculus | GSE127998 ... | MA0499.2 |
MYOD1 | primary myoblasts | Conditions: Growth Media; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2; | Permissive Robust | Mus musculus | GSE127998 ... | MA0499.2 |
MYOD1 | primary myoblasts | Conditions: differentiation medium; Genotype: Twist2-CreERT2 tdTO (Twist2 overexpression); Treatment: infected with 3xTy1-Twist2; | Permissive Robust | Mus musculus | GSE127998 ... | MA0499.2 |
MYOD1 | myocytes | Permissive Robust | Mus musculus | ENCSR000AIH ... | MA0499.2 | |
MYOD1 | myocytes | Permissive Robust | Mus musculus | ENCSR000AIR ... | MA0499.2 | |
MYOD1 | myocytes | Permissive Robust | Mus musculus | ENCSR000AIT ... | MA0499.2 | |
MYOD1 | C2C12 (myoblasts) | Permissive Robust | Mus musculus | ENCSR000AIG ... | MA0499.2 | |
MYOD1 | myoblasts | Permissive Robust | Mus musculus | GSE24852 ... | MA0499.2 | |
MYOD1 | fibroblasts | Permissive Robust | Mus musculus | GSE24852 ... | MA0499.2 | |
MYOD1 | P19 (embryonic carcinoma) | Permissive Robust | Mus musculus | GSE34906 ... | MA0499.2 | |
MYOD1 | embryonic fibroblasts | Permissive Robust | Mus musculus | GSE34906 ... | MA0499.2 | |
MYOD1 | C2C12 (myoblasts) | Permissive Robust | Mus musculus | GSE44824 ... | MA0499.2 | |
MYOD1 | C2C12 (myoblasts) | Permissive Robust | Mus musculus | GSE49313 ... | MA0499.2 | |
MYOD1 | C2C12 (myoblasts) | Permissive Robust | Mus musculus | GSE49313 ... | MA0499.2 | |
MYOD1 | brown preadipocytes | Permissive | Mus musculus | GSE50465 ... | MA0499.2 | |
MYOD1 | brown preadipocytes | Permissive | Mus musculus | GSE50465 ... | MA0499.2 | |
MYOD1 | brown preadipocytes | Permissive Robust | Mus musculus | GSE50465 ... | MA0499.2 | |
MYOD1 | myoblasts | Permissive Robust | Mus musculus | GSE56077 ... | MA0499.2 | |
MYOD1 | embryonic fibroblasts | Permissive Robust | Mus musculus | GSE75370 ... | MA0499.2 | |
MYOD1 | C2C12 (myoblasts) | Permissive Robust | Mus musculus | GSE63716 ... | MA0499.2 | |
MYOD1 | RH4 (alveolar rhabdomyosarcoma) | Permissive Robust | Homo sapiens | GSE83726 ... | MA0499.2 | |
MYOD1 | dermal fibroblasts | Permissive Robust | Homo sapiens | GSE93258 ... | MA0499.2 | |
MYOD1 | myoblasts | Permissive Robust | Homo sapiens | GSE50413 | MA0499.2 | |
MYOD1 | rhabdomyosarcoma | Permissive Robust | Homo sapiens | GSE50413 | MA0499.2 |